AZ6102
NAD+ competitive inhibitor of TNKS, TNKS2
Structure
In Cells
In Model Organisms
SERP ratings and comments
SERP Ratings
SERP Comments:
AZ6102 shows good inhibition of TNK1/2 with selectivity against other related enzymes of the PARP family. Data about other potential off targets (e.g., other NAD+-dependent enzymes or protein kinases) are not shown. AZ6102 has an IC50 in the same low nanomolar range for the isolated enzyme (TNKS1) as well as in the cellular assays. This could be a hint that AZ6102 also interferes with targets other than PARPs in cells. Experiments in a xenograft model with AZ6102 have been announced by the authors, but they are not yet published.
(last updated: 12 Aug 2016 )
SERP Ratings
(last updated: 20 Jan 2017 )
SERP Ratings
SERP Comments:
Although two independent papers report that this is a potent (low nM) TNKS2 inhibitor, they report significant discrepancies in TNKS1 inhibition (3 and 100 nM). The oral bioavailability is modest (F = 12% mouse, 18% rat), so it would probably be best to stick to IV formulations.
(last updated: 11 Apr 2017 )